The following is a guest article by Haim Neerman, CEO at Variantyx. As a society, how much should be invested in creating a “transformative textbook of medicine, with insights that will give health care providers immense new power to treat, prevent and cure disease”? In this case, it is a trick question. The investment has […]
Show CommentsClose Comments